Last reviewed · How we verify
NCT04077762: REBIRTH
Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH)
NA trial testing Radial Access in Patient Satisfaction in 3,266 participants. Currently enrolling.
19 August 2027
Quick facts
| Lead sponsor | Minneapolis Heart Institute Foundation |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 3,266 |
| Start date | 15 November 2019 |
| Primary completion | 19 August 2027 |
| Estimated completion | 19 August 2028 |
| Sites | 6 locations across United States |
Drugs / interventions tested
- Radial Access
- State-of-the-art femoral access with 18 gauge needle
- State-of-the-art femoral access with 21 gauge needle
Conditions studied
- Patient Satisfaction — all drugs for Patient Satisfaction →
- Vascular Access Complication — all drugs for Vascular Access Complication →
Sponsor
Minneapolis Heart Institute Foundation
Who can join
18 and older, any sex, with Patient Satisfaction or Vascular Access Complication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a phase IV, prospective, open label, randomized-controlled study that will compare radial access with state-of-the-art femoral access in patients without ST-segment elevation acute myocardial infarction undergoing cardiac catheterization. Subjects will be randomized 1:1 into 2 treatment groups: radial access and state-of-the-art femoral access. Randomization will be performed in blocks of 50 per site. Similarly, a second sub-randomization will be performed in the femoral access group into use of 18 vs 21 gauge needles, also in a 1:1 fashion.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Ultrasound guidance for arterial (other than femoral) catheterisation in adults.
Flumignan RL, Trevisani VF, Lopes RD, Baptista-Silva JC, et al · · 2021 · cited 11× · PMID 34637140 · DOI 10.1002/14651858.cd013585.pub2 -
Ultrasound-Guided Femoral Vascular Access for Percutaneous Coronary and Structural Interventions.
Xenogiannis I, Varlamos C, Keeble TR, Kalogeropoulos AS, et al · · 2023 · cited 6× · PMID 37370923 · DOI 10.3390/diagnostics13122028
Verify or expand the search:
- PubMed search for NCT04077762
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Patient Satisfaction
Currently open trials in the same condition.
- NCT07464080 — Advanced Brain Imaging-TKA (fMRI-TKA) · NA · recruiting
- NCT07311525 — Ultrasound-Guided RSCTL vs EOIP Block for Analgesia in Sleeve Gastrectomy · NA · recruiting
- NCT07517926 — Chewing Gum and Cold Gargle on Post-Bronchoscopy Symptoms · NA · recruiting
- NCT06975033 — Educational Discharge Video Impact on Post-Operative Healthcare Utilization After HoLEP · NA · recruiting
- NCT07274072 — Hospital at Home Versus Inpatient Care: Costs and Effectiveness · recruiting
Other Minneapolis Heart Institute Foundation trials
Trials by the same sponsor.
- NCT06804980 — DESIFOR-EXPAND (MHIF) · Phase 4 · recruiting
- NCT04763460 — Effects of CRT Optimization as Assessed by Cardiac MR · NA · withdrawn
- NCT05440084 — Impact of CTO PCI (Chronic Total Occlusion Percutaneous Intervention) on Regular Physical Activity · terminated
- NCT05065073 — Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography · Phase 4 · unknown
- NCT05100940 — Progress Complication · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04077762 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Minneapolis Heart Institute Foundation
- Last refreshed: 24 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04077762.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing